JanetRWozniakMD

Child & Adolescent Psychiatry

Chair, Quality and Safety Department of Psychiatry; Director, Child and Adolescent Outpatient Service; and Director, Pediatric Bipolar Disorder Clinical and Research Program, Massachusetts General Hospital. Associate Professor of Psychiatry, Harvard Medical School.

Join to view full profile

Dr. Wozniak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wozniak's full profile

Already have an account?

Office
55 Fruit St
Massachusetts General Hospital
Boston, MA 02114
Phone+1 617-724-5600

Fax+1 617-726-5567

Education & Training

Massachusetts General Hospital/McLean HospitalFellowship, Child and Adolescent Psychiatry, 1990 - 1992
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1990
University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1987 - 1988
Weill Cornell MedicineClass of 1987

Certifications & Licensure

CA State Medical License 1993 - 2025
MA State Medical License 1989 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder Start of enrollment: 2003 Jun 01
Completed
Phase 4
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS) Start of enrollment: 2003 Dec 01
Completed
Phase 4
Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder Start of enrollment: 2005 Jan 01
Completed
Phase 4
Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder Start of enrollment: 2005 Jul 01
Completed
Phase 4
Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder Start of enrollment: 2005 Feb 01
Completed
Phase 4
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder Start of enrollment: 2007 Nov 01
Terminated
Phase 4
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents Start of enrollment: 2007 Dec 01
Terminated
Phase 4
Effect of Vyvanse on Driving in Young Adults With ADHD Start of enrollment: 2008 Dec 01
Completed
Phase 4
Inositol and Omega-3 Fatty Acids in Pediatric Mania Start of enrollment: 2012 Feb 03
Completed
Phase 4
A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder Start of enrollment: 2014 Apr 01
Completed
Phase 2
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) Start of enrollment: 2019 May 20
Recruiting
Phase 4
A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth Start of enrollment: 2019 Jun 18
Recruiting
Phase 4
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment.
Janet Wozniak, Hannah O'Connor, Maria Iorini, Adrian Jacques H Ambrose
Paediatric Drugs. 2024-11-27
In Memoriam: Professor Joseph Biederman's Contributions to Child and Adolescent Psychiatry.
Stephen V Faraone, Jeffrey H Newcorn, Janet Wozniak, Gagan Joshi, Barbara Coffey
Journal of Attention Disorders. 2024-03-01
In Memoriam: Professor Joseph Biederman's Contributions to Child and Adolescent Psychiatry.
Stephen V Faraone, Jeffrey H Newcorn, Janet Wozniak, Gagan Joshi, Barbara Coffey
Journal of Attention Disorders. 2024-03-01

Press Mentions

The Woz Surprises Biomedical Scientists Working on CoronavirusApril 25th, 2020
Predictive Utility of Autistic Traits in Youth with ADHD: A Controlled 10-Year Longitudinal Follow-up StudyAugust 29th, 2019
Comorbid Bipolar I Disorder and Conduct Disorder May Represent a Distinct Familial SubtypeMarch 19th, 2019
Join now to see all